- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05219422
Testing ALERT With GTO in Middle Schools (GTO-ALERT)
April 26, 2024 updated by: Matthew Chinman, RAND
Improving the Implementation of Evidence-based Drug Prevention Programs in Schools
To test the efficacy of Project ALERT with the support enhancement tool, Getting To Outcomes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study combines two programs that have been developed by RAND researchers: Project ALERT (PA) and Getting to Outcomes (GTO).
Project ALERT is a widely used drug prevention program for middle school youth.
Though it has an evidence-base for effectiveness, the program (like most evidence-based programs in schools) is not run with adequate fidelity representing a large gap between what is developed and tested for effectiveness and what is used in actual practice.
Thus, the study will conduct an updated randomized controlled trial of PA and test GTO as a tool to increase adoption and adequate fidelity of the program in schools.
GTO's previous evidence suggests it could be effective in public schools, yet this remains an empirical question.
A successful demonstration of PA and GTO could fundamentally transform evidence-based prevention's delivery, reach, and thus impact, in the US.
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Matthew Chinman, PhD
- Phone Number: 4287 310-393-0411
- Email: chinman@rand.org
Study Contact Backup
- Name: Eric Pedersen, PhD
- Phone Number: 323-442-4046
- Email: Eric.Pedersen@med.usc.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 90017
- Recruiting
- Los Angeles Unified School District
-
Contact:
- Tim Kordic
- Phone Number: 213-241-3519
- Email: timothy.kordic@lausd.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 70 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Eligibility for student participants: all students in 7th grade, primarily aged 12-14, attending school at one of the enrolled schools in the study.
- Eligibility for school staff participants: all educators interested in enrolling in the study at each of the enrolled schools.
Exclusion Criteria:
- Not meeting eligibility criteria
Note: the age range is from 11 to 70 to account for both the student AND teacher populations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Project ALERT only
Some schools will be randomized to receive Project ALERT only for 3 years starting fall 2022.
|
14 session drug prevention program for 7th and 8th grade youth.
|
Active Comparator: Project ALERT plus GTO
Some schools will be randomized to receive Project ALERT plus Getting to Outcomes for 3 years starting fall 2022.
|
14 session drug prevention program for 7th and 8th grade youth.
The Getting To Outcomes (GTO) implementation support intervention provides technical assistance, training, guides, and tools to improve community-based practitioners capacity to complete tasks associated with implementing an EBP, which in turn leads to improved implementation fidelity.
|
No Intervention: Status quo
Some schools not receive either Project ALERT or Project ALERT plus GTO until year 3 of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Student resistance self-efficacy
Time Frame: Changes assessed for past year self-efficacy use at each follow-up point from baseline
|
Resistance self-efficacy from the Project ALERT survey measures avoiding use of all 6 drugs in risky situations.
Measure is posted on the Project ALERT website and utilized in the 4 prior RCTs of Project ALERT.
|
Changes assessed for past year self-efficacy use at each follow-up point from baseline
|
Student alcohol and drug behavior
Time Frame: Changes assessed for past year use at each follow-up point from baseline
|
Alcohol and drug use will be assessed for alcohol, cigarettes, marijuana, e-cigarettes, prescription opioids, and heroin (lifetime, past month, past year use), allowing us to evaluate program effects on ever, past month, and weekly use.
We will assess marijuana and nicotine using items to capture nuanced products (e.g., JUUL/vape pens) and include combinations of marijuana/nicotine products to assess co-use, such as using a vaporizer to vape both nicotine e-liquid and cannabis oil.
For alcohol, we will ask questions that allow us to construct 3 alcohol misuse scales: (1) alcohol-related consequences (sum of 5 dichotomous questions on: getting sick, getting in a physical fight, getting in trouble at school, getting in trouble at home, doing something he/she later regretted); (2) high-risk drinking (sum of 3 dichotomous variables: binge drinking in the past month, polydrug use of alcohol and marijuana in the past year, weekly drinking); and (3) overall misuse (sum of above 8 variables).
|
Changes assessed for past year use at each follow-up point from baseline
|
Student pro-substance use risk factors on consequences
Time Frame: Changes assessed for past year consequences of use at each follow-up point from baseline
|
Beliefs about the short- and long-term consequences (positive and negative).
Measures come from the Project ALERT survey posted on the Project ALERT website and utilized in the 4 prior RCTs of Project ALERT.
|
Changes assessed for past year consequences of use at each follow-up point from baseline
|
Student pro-substance use risk factors on perceived norms
Time Frame: Changes assessed for past year perceived peer use at each follow-up point from baseline
|
Normative beliefs about the prevalence of use and its acceptability to others, including peers and parents.
Measures come from the Project ALERT survey posted on the Project ALERT website and utilized in the 4 prior RCTs of Project ALERT.
|
Changes assessed for past year perceived peer use at each follow-up point from baseline
|
Student pro-substance use risk factors on expectancies
Time Frame: Changes assessed for past year use at each follow-up point from baseline
|
Expectations of drug use in the next 6 months.
Measures come from the Project ALERT survey posted on the Project ALERT website and utilized in the 4 prior RCTs of Project ALERT.
|
Changes assessed for past year use at each follow-up point from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Matthew Chinman, PhD, RAND
- Principal Investigator: Eric Pedersen, PhD, University of Southern California
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2020
Primary Completion (Estimated)
March 30, 2025
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
September 14, 2021
First Submitted That Met QC Criteria
January 20, 2022
First Posted (Actual)
February 2, 2022
Study Record Updates
Last Update Posted (Actual)
April 30, 2024
Last Update Submitted That Met QC Criteria
April 26, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-0121-AM01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Abuse
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)United States
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)
-
National Institute on Drug Abuse (NIDA)CompletedDrug/Substance Abuse/Addiction | Alcohol Abuse/AddictionUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse, IntravenousUnited States
-
Sheidow Consulting, Inc.Oregon Social Learning CenterCompletedSubstance Abuse ProblemUnited States
-
Penn State UniversityCompletedSubstance Abuse ProblemUnited States
-
National Institute on Drug Abuse (NIDA)CompletedSubstance Abuse | Drug Abuse | Alcohol AbuseUnited States
-
University of California, IrvineUS Department of Veterans AffairsWithdrawn
Clinical Trials on Project ALERT
-
Pacific Institute for Research and EvaluationCompletedSmoking | Alcohol Drinking | Marijuana SmokingUnited States
-
Brigham and Women's HospitalSanofiCompletedDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Prevention | ProphylaxisUnited States
-
Columbia UniversityEnrolling by invitationSepsis | Electronic Health Records | Clinical Decision Support SystemsUnited States
-
Columbia UniversityEnrolling by invitationSepsis | Electronic Health Records | Clinical Decision Support SystemsUnited States
-
University of California, San FranciscoCompleted
-
Imperial College LondonCompletedType1diabetesUnited Kingdom
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Gastrointestinal Cancer | Oral Cancer Directed Therapy | Oral ChemotherapyUnited States
-
Stanford UniversityCompleted
-
Cedars-Sinai Medical CenterTerminated